Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Bryn Mawr Bank Adopts Poison Pill Strategy

Bryn Mawr Bank Corporation (BMTC: Quote) Wednesday said its Board has adopted a shareholder rights agreement, commonly called poison pill strategy. The company will distribute one common stock purchase right as a dividend on each share to shareholders as of December 1, 2012.

Chief Executive Ted Peters said, "The Board believes that adopting the Rights Agreement continues to enhance our ability to protect shareholder interests and ensure that shareholders receive fair treatment in the event of any takeover attempt.The Rights Agreement is intended to provide the Board with sufficient time to consider any and all alternatives to such an action."

As per the agreement, the rights become exercisable if any person or group acquires 15 percent or more of the company's stock. The rights are set to expire on November 16, 2015.

Click here to receive FREE breaking news email alerts for Bryn Mawr Bank Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The U.K. economy grew at a slower pace in the third quarter in the face of rising uncertainty stemming from global economic conditions, preliminary estimates from the Office for National Statistics Office showed Friday. Gross domestic product climbed 0.7 percent from the second quarter, when it grew 0.9 percent. German consumer climate is set to improve slightly in November, ending the downward trend, as income expectations among households strengthened on the back of the strong labor market situation, survey data revealed Friday.The forward-looking consumer confidence index rose slightly to 8.5 in November from 8.4 in October. Software giant Microsoft Corp. said Thursday after the markets closed that its first quarter profit fell 13% from last year, hurt mainly by integration and restructuring costs even as revenue surged 25% thanks to strong sales of its gadgets and cloud-based products. However, the company's quarterly earnings per share came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.